Candice Clay, Ph.D.

Candice Clay, Ph.D., has a diverse work experience in the field of medical science and research. From 2008 to 2010, they worked as a Postdoctoral Researcher at the Lovelace Respiratory Research Institute, where they focused on characterizing the immunopathogenesis of infectious respiratory diseases and identifying immune correlates of protection for vaccine and therapeutic development. From 2010 to 2015, they held a similar position at UC Davis, conducting research on pediatric immune responses to respiratory viruses and vaccines, with a particular focus on improving immunity in neonatal hosts. In 2014, Candice joined Theravance Biopharma US, Inc., where they worked in various roles, including as a Medical Science Liaison and Clinical Trial Liaison, Senior Medical Science Liaison Regional Manager, and Medical Science Liaison Regional Manager. Their responsibilities involved establishing and maintaining scientific relationships with healthcare professionals, providing education on therapeutic products, and supporting clinical trials. Currently, they serve as the Field Medical Director at Verona Pharma, where they likely leads the coordination of medical affairs activities and engagement with healthcare providers. Overall, Candice Clay's work experience demonstrates their expertise in medical science, clinical research, and respiratory diseases.

Candice Clay, Ph.D. pursued their education in a progressive manner, starting with a Bachelor of Science (BS) degree in Cell/Cellular and Molecular Biology from the University of California, Davis. Candice completed this program from 1997 to 2001. Following their bachelor's degree, they continued their studies at the same institution and obtained a Doctor of Philosophy (PhD) degree in Immunology from the University of California, Davis between 2001 and 2007.

In addition to their formal education, Candice Clay also obtained several certifications. In 2013, they completed the "SciWrite Writing in the Sciences" certification program from Stanford University. Furthermore, they acquired the "Board Certified Medical Affairs Specialist" certification from the Accreditation Council for Medical Affairs (ACMA) in December 2020.

Lastly, it is mentioned that Candice Clay has an additional certification titled "Epigenetic Control of Gene Expression," however, no specific information is provided regarding the institution or the year of completion for this particular certification.